I like the way you are thinking on this. And wow, I might like it as I said before you’ve got people in the basement doing research you have a budget and might say a $4 billion injection into a new company to move a product along is great, but that blows our entire budget for the year. The bean counters who are looking at only a one year or three year or five year budget might say that Rees as well But the medical scientists are saying yes we need this and of course commercial is saying we’re pushing a product now that is going off patent so please make this deal. So there are internal battles within individual biotech companies that prevent the head from agreeing with the tail while the hooves want to run

But I agree with you. Five or seven patients alive is sure better than anything else out there and if I were big Pharma, I put money on this horse. Hell, the hoes are already moving. It’s just the tail in the head that are sagging.